Zimmer Biomet Names Medtronic Executive as CEO

Musculoskeletal health-care company Zimmer Biomet Holdings Inc. (ZBH) on Tuesday said it named Medtronic PLC (MDT) executive Bryan Hanson as president and chief executive.

Mr. Hanson was president of Medtronic's Minimally Invasive Therapies Group and had worked at the company since 2015, when Medtronic bought Covidien, his former employer.

Medtronic said Bob White, senior vice president and president of its Asia Pacific region, will take over Mr. Hanson's former role.

Zimmer Biomet Chief Financial Officer Daniel Florin, who has running the company as interim CEO since July, will remain chief financial officer.

Shares of Indiana-based Zimmer Biomet rose 0.5% on low volume premarket. Medtronic shares were flat.

Write to Allison Prang at allison.prang@wsj.com

(END) Dow Jones Newswires

December 19, 2017 09:30 ET (14:30 GMT)